Patents by Inventor Shun xin Wang lin

Shun xin Wang lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952426
    Abstract: Methods of treating cancers using a BCMAxCD3 bispecific antibody are described.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: April 9, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Homer Adams, Arnob Banerjee, Suzette Girgis, Jenna Goldberg, Tara Stephenson, Raluca Verona, Shun xin Wang lin
  • Publication number: 20230295292
    Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics. In particular, methods are disclosed of using a GPRC5DxCD3 bispecific antibody, an anti-CD38 antibody and/or pomalidomide to treat cancers.
    Type: Application
    Filed: November 2, 2022
    Publication date: September 21, 2023
    Inventors: Jenna Goldberg, Shun Xin Wang Lin, Thomas J. Prior, Raluca Verona, Brendan Weiss
  • Publication number: 20220373550
    Abstract: Methods of monitoring progression of multiple myeloma or plasmacytoma, particularly relapsed or refractory multiple myeloma, are described. Also described are methods of treating or determining response to a treatment for multiple myeloma or plasmacytoma in a subject.
    Type: Application
    Filed: May 11, 2022
    Publication date: November 24, 2022
    Inventors: Kodandaram Pillarisetti, Suzette Girgis, Jenna Goldberg, Shun Xin Wang Lin
  • Publication number: 20220041742
    Abstract: Methods of treating cancers using a BCMAƗCD3 bispecific antibody are described.
    Type: Application
    Filed: May 11, 2021
    Publication date: February 10, 2022
    Inventors: Homer Adams, Arnob Banerjee, Suzette Girgis, Jenna Goldberg, Tara Stephenson, Raluca Verona, Shun xin Wang lin